Quick Answer
vTv Therapeutics Inc. reported Stockholders Equity of $64.44 million for fiscal year 2025.
vTv Therapeutics Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $64.44M | +428.2% |
| 2024 | $12.20M | +149.4% |
| 2023 | -$24.68M | -129.8% |
| 2022 | -$10.74M | -10.3% |
| 2021 | -$9.74M | +87.8% |
| 2020 | -$80.10M | -63.4% |
| 2019 | -$49.02M | +40.8% |
| 2018 | -$82.85M | +45.1% |
| 2017 | -$151.05M | -66.1% |
| 2016 | -$90.94M | -16.6% |
| 2015 | -$77.97M | +84.4% |
| 2014 | -$498.81M | -64.2% |
| 2013 | -$303.73M | -68.6% |
| 2012 | -$180.17M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $70.54M | +370.0% | +2454.1% |
| June 30, 2025 | $2.76M | -83.2% | -65.1% |
| March 31, 2025 | $7.92M | -61.9% | -35.1% |
| December 31, 2024 | $12.20M | +149.4% | -18.7% |
| September 30, 2024 | $15.01M | +159.5% | -8.9% |
| June 30, 2024 | $16.48M | +165.2% | -20.8% |
| March 31, 2024 | $20.80M | +208.4% | +184.3% |
| December 31, 2023 | -$24.68M | -129.8% | +2.2% |
- vTv Therapeutics Inc. showed an increase of +428.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, vTv Therapeutics Inc.’s stockholders equity has grown by 135.8% (from -$180.17 million to $64.44 million).
- The most recent figure is from vTv Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: